FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2777644429> ?p ?o ?g. }

• W2777644429 endingPage "599" @default.
• W2777644429 startingPage "587" @default.
• W2777644429 abstract "Cancer immunotherapy with human γδ T cells expressing Vγ2Vδ2 T cell receptor (also termed Vγ9Vδ2) has shown promise because of their ability to recognize and kill most types of tumors in a major histocombatibility complex ( MHC ) ‐unrestricted fashion that is independent of the number of tumor mutations. In clinical trials, adoptive transfer of Vγ2Vδ2 T cells has been shown to be safe and does not require preconditioning. In this report, we describe a method for preparing highly enriched human Vγ2Vδ2 T cells using the bisphosphonate prodrug, tetrakis‐pivaloyloxymethyl 2‐(thiazole‐2‐ylamino)ethylidene‐1,1‐bisphosphonate ( PTA ). PTA stimulated the expansion of Vγ2Vδ2 cells to purities up to 99%. These levels were consistently higher than those observed after expansion with zoledronic acid, the most commonly used stimulator for clinical trials. Cell numbers also averaged more than those obtained with zoledronic acid and the expanded Vγ2Vδ2 cells exhibited high cytotoxicity against tumor cells. The high purity of Vγ2Vδ2 cells expanded by PTA increased engraftment success in immunodeficient NOG mice. Even low levels of contaminating αβ T cells resulted in some mice with circulating human αβ T cells rather than Vγ2Vδ2 cells. Vγ2Vδ2 cells from engrafted NOG mice upregulated CD 25 and secreted tumor necrosis factor‐α and interferon‐γ in response to PTA ‐treated tumor cells. Thus, PTA expands Vγ2Vδ2 T cells to higher purity than zoledronic acid. The high purities allow the successful engraftment of immunodeficient mice without further purification and may speed up the development of allogeneic Vγ2Vδ2 T cell therapies derived from HLA ‐matched normal donors for patients with poor autologous Vγ2Vδ2 T cell responses." @default.
• W2777644429 created "2018-01-05" @default.
• W2777644429 creator A5002212423 @default.
• W2777644429 creator A5003334672 @default.
• W2777644429 creator A5014642139 @default.
• W2777644429 creator A5019793260 @default.
• W2777644429 creator A5032830362 @default.
• W2777644429 creator A5033020983 @default.
• W2777644429 creator A5035735834 @default.
• W2777644429 creator A5042787337 @default.
• W2777644429 creator A5053350086 @default.
• W2777644429 creator A5057490410 @default.
• W2777644429 creator A5072115685 @default.
• W2777644429 creator A5075807220 @default.
• W2777644429 creator A5086521398 @default.
• W2777644429 creator A5091245889 @default.
• W2777644429 creator A5091912982 @default.
• W2777644429 date "2018-02-04" @default.
• W2777644429 modified "2023-10-16" @default.
• W2777644429 title "Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug" @default.
• W2777644429 cites W1195955210 @default.
• W2777644429 cites W1535243328 @default.
• W2777644429 cites W1593246933 @default.
• W2777644429 cites W1809672664 @default.
• W2777644429 cites W1972245883 @default.
• W2777644429 cites W1972525178 @default.
• W2777644429 cites W1992794673 @default.
• W2777644429 cites W2009704944 @default.
• W2777644429 cites W2009888206 @default.
• W2777644429 cites W2017453418 @default.
• W2777644429 cites W2018540827 @default.
• W2777644429 cites W2032404890 @default.
• W2777644429 cites W2036501031 @default.
• W2777644429 cites W2043545955 @default.
• W2777644429 cites W2043756084 @default.
• W2777644429 cites W2049553585 @default.
• W2777644429 cites W2059572118 @default.
• W2777644429 cites W2060196382 @default.
• W2777644429 cites W2073312795 @default.
• W2777644429 cites W2073334951 @default.
• W2777644429 cites W2073863670 @default.
• W2777644429 cites W2074671087 @default.
• W2777644429 cites W2095220820 @default.
• W2777644429 cites W2098528749 @default.
• W2777644429 cites W2100915708 @default.
• W2777644429 cites W2101653483 @default.
• W2777644429 cites W2116738410 @default.
• W2777644429 cites W2127367385 @default.
• W2777644429 cites W2129035692 @default.
• W2777644429 cites W2138922046 @default.
• W2777644429 cites W2151823004 @default.
• W2777644429 cites W2152061559 @default.
• W2777644429 cites W2153901715 @default.
• W2777644429 cites W2160834915 @default.
• W2777644429 cites W2170263258 @default.
• W2777644429 cites W2206208191 @default.
• W2777644429 cites W2232549736 @default.
• W2777644429 cites W2399328737 @default.
• W2777644429 cites W2543801074 @default.
• W2777644429 cites W2582261102 @default.
• W2777644429 cites W2735659715 @default.
• W2777644429 cites W2736193208 @default.
• W2777644429 cites W2747774814 @default.
• W2777644429 cites W2760825739 @default.
• W2777644429 cites W2767999152 @default.
• W2777644429 doi "https://doi.org/10.1111/cas.13491" @default.
• W2777644429 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5834800" @default.
• W2777644429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29288540" @default.
• W2777644429 hasPublicationYear "2018" @default.
• W2777644429 type Work @default.
• W2777644429 sameAs 2777644429 @default.
• W2777644429 citedByCount "31" @default.
• W2777644429 countsByYear W27776444292018 @default.
• W2777644429 countsByYear W27776444292019 @default.
• W2777644429 countsByYear W27776444292020 @default.
• W2777644429 countsByYear W27776444292021 @default.
• W2777644429 countsByYear W27776444292022 @default.
• W2777644429 countsByYear W27776444292023 @default.
• W2777644429 crossrefType "journal-article" @default.
• W2777644429 hasAuthorship W2777644429A5002212423 @default.
• W2777644429 hasAuthorship W2777644429A5003334672 @default.
• W2777644429 hasAuthorship W2777644429A5014642139 @default.
• W2777644429 hasAuthorship W2777644429A5019793260 @default.
• W2777644429 hasAuthorship W2777644429A5032830362 @default.
• W2777644429 hasAuthorship W2777644429A5033020983 @default.
• W2777644429 hasAuthorship W2777644429A5035735834 @default.
• W2777644429 hasAuthorship W2777644429A5042787337 @default.
• W2777644429 hasAuthorship W2777644429A5053350086 @default.
• W2777644429 hasAuthorship W2777644429A5057490410 @default.
• W2777644429 hasAuthorship W2777644429A5072115685 @default.
• W2777644429 hasAuthorship W2777644429A5075807220 @default.
• W2777644429 hasAuthorship W2777644429A5086521398 @default.
• W2777644429 hasAuthorship W2777644429A5091245889 @default.
• W2777644429 hasAuthorship W2777644429A5091912982 @default.
• W2777644429 hasBestOaLocation W27776444291 @default.
• W2777644429 hasConcept C108215921 @default.
• W2777644429 hasConcept C126322002 @default.
• W2777644429 hasConcept C153911025 @default.

• next